What sector does Acadia Pharmaceuticals belong to?
Acadia Pharmaceuticals operates in the Health Care sector, specifically the Pharmaceuticals industry, and is listed on the US markets.
What is the current share price of ACAD?
As of the latest available quote, ACAD traded at $27.83. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of ACAD?
Acadia Pharmaceuticals has a price-to-earnings (P/E) ratio of about 12.48. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of ACAD?
The market capitalisation of Acadia Pharmaceuticals is approximately $4.73B.
Is Acadia Pharmaceuticals profitable?
For its latest reported financial year, Acadia Pharmaceuticals recorded a net profit margin of about 36.49%.
Does ACAD pay a dividend?
Acadia Pharmaceuticals does not currently show a dividend yield in our data.
What is the return on equity (ROE) of ACAD?
Acadia Pharmaceuticals has a return on equity (ROE) of about 29.92%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of ACAD?
Over the past 52 weeks, ACAD has traded between a low of $19.69 and a high of $30.96.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.